Pelvic Inflammatory Disease

Daniel Abehsera (Editor)
Obstetrics and Gynecology Department Quirón University Hospital Málaga, Spain

Series: Obstetrics and Gynecology Advances
BISAC: MED033000

Clear

$82.00

Volume 10

Issue 1

Volume 2

Volume 3

Special issue: Resilience in breaking the cycle of children’s environmental health disparities
Edited by I Leslie Rubin, Robert J Geller, Abby Mutic, Benjamin A Gitterman, Nathan Mutic, Wayne Garfinkel, Claire D Coles, Kurt Martinuzzi, and Joav Merrick

eBook

Digitally watermarked, DRM-free.
Immediate eBook download after purchase.

Product price
Additional options total:
Order total:

Quantity:

Details

Pelvic inflammatory disease (PID) is an entity whose diagnosis is not always easy. The PID comprises a wide range of clinical forms ranging from banal to severe disease processes that compromise the life of the patient. The etiologic diagnosis is not always possible, because the germs responsible cannot always be detected by the usual culture medium, which is why the use of molecular biology techniques is required. The classical definition of PID is a secondary infection of the female genital tract, due to infection of a sexually transmitted disease like Chlamydia trachomatis, or Neisseria gonorrhea. This notion is being displaced by the concept of PID as a secondary infection by a germ from the altered vaginal flora.

The interpretation of complementary tests is difficult because severe cases can present with normal analytical profiles, and an absence of findings on imaging tests. Usually, when an image of pelvic abscess is observed, it usually indicates a failure of medical treatments; however, it is possible to perform a step prior to surgical treatment by ultrasound-guided puncture of the abscess. The use of laparoscopy in the PID is very important for both diagnosis and treatment when there is a failure of drug therapy. An early approach to the disease is essential to prevent damage in the female genital tract that will compromise the fertility of the patient in the future.
(Imprint: Nova Medicine and Health)

Preface

Chapter 1. Concept and Epidemiology
(Daniel Abehsera MD, PhD, and Andrés C. López, MD, PhD, Obstetrics and Gynecology Department, Quirónsalud Hospital, Málaga, Spain)

Chapter 2. Clinical Manifestations and Diagnostic Criteria
(Laura Baños, MD, and Jessica Martín, MD, Obstetrics and Gynecology Department, Quirónsalud Hospital, Málaga, Spain)

Chapter 3. Microbiology of the Pelvic Inflammatory Disease. Molecular Biology Techniques
(Laura López, MD, and Paula Chamocho, MD, Obstetrics and Gynecology Department, Quirónsalud Hospital, Málaga, Spain)

Chapter 4. Risk Factors: Routes of Disease Transmission
(Marta de la Peña, MD, Marta Casaus, MD, and Araceli Sánchez, MD, Obstetrics and Gynecology Department, Quirónsalud Hospital, Málaga, Spain)

Chapter 5. Complementary Tests in Pelvic Inflammatory Disease
(Raquel P. Duarte, MD, PhD, Aurelia Marsac, MD, and Lourdes Martínez, MD, Hospital Quironsalud Málaga, Obstetrics and Gynecology Department, Málaga, Spain)

Chapter 6. Pharmacological Treatment
(Azucena Molina, MD, Isabel Lozano, MD, Gemma Marín, MD, Obstetrics and Gynecology Department, Quirónsalud Hospital, Málaga, Spain)

Chapter 7. Surgical Treatment: The Role of Laparoscopy
(Sadia Chocrón, MD, and Milagros Gálvez, MD, Obstetrics and Gynaecology Department, Quirónsalud Hospital, Málaga, Spain)

Chapter 8. Complications and Consequences of Pelvic Inflammatory Disease
(Marta García, MD, Celia Cuenca, MD, PhD, Obstetrics and Gynecology Department, Quirónsalud Hospital, Málaga, Spain)

Index

Keywords: Pelvic inflammatory disease, Sexually transmitted infection, Endometritis, Tubo – ovarian abscess

You have not viewed any product yet.